Summary
Machine-generated summaryThe Czech contracting authority is procuring recurring supplies of medicinal products containing the active substance lenvatinib, as part of a public tender for antineoplastics and immunomodulators. The products delivered must meet the requirements of the State Institute for Drug Control (SUKL). The procurement covers repeated deliveries of these medicines under the announced framework. No estimated value, submission deadline, or specific procedure details are stated in the available information. Suppliers of medicinal products meeting SUKL requirements may participate in this tender.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile44 open tenders right now
- Medical needles - Echogenic needle 1 day left
- Vascular prostheses - Linear ePTFE vascular prosthesis 1 day left
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 2 days left
Recent awards
Similar tenders
1
day left
€548,450
est. value
1
day left
€1,436,973
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,804,288
- Buyer track record on Aperlena
- 761 notices tracked · 400 awarded
- €531,888,821 in awarded contracts
Never miss a tender like this
149 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert